October 16, 2019
Editas and AskBio Team Up to Develop Novel Treatments for Neurological Diseases
Read More
October 16, 2019
Ipsen Expands Its Rare Disease Portfolio with License for Blueprint Medicines’ FOP Treatment
Read More
October 16, 2019
Alexion Adds to Rare Disease Pipeline with Acquisition of Achillion
Read More
October 10, 2019
Alexion Pays Stealth $30 Million for Option to Co-Develop Late-Stage Program in Mitochondrial Diseases
Read More
October 10, 2019
UCB to Acquire Ra Pharmaceuticals in Deal Valued at $2.1 Billion
Read More
October 10, 2019
Reata Pays $330 Million to Reacquire Drug Rights from AbbVie
Read More
October 9, 2019
Bluebird Bio and Novo Nordisk Team Up to Develop Genome Editing Therapies
Read More
October 8, 2019
Akcea Grants Pfizer Exclusive License to Antisense Therapy
Read More
October 4, 2019
Goldfinch Enters Licensing Agreement with Takeda for Rare And Metabolic Kidney Diseases
Read More
October 1, 2019
NewLink Genetics and Lumos Merge to Focus on Rare Disease Therapies
Read More
September 30, 2019
Ocugen and CanSino Biologics Enter Gene Therapy Strategic Partnership
Read More
September 25, 2019
Amryt Raises $60 Million as It Completes Acquisition of Aegerion
Read More
Load More
X